Guangzhou Jet Biofiltration Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003RQ9
CNY
16.43
-0.43 (-2.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
548.84
456.32
602.29
852.15
500.68
245.26
204.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
548.84
456.32
602.29
852.15
500.68
245.26
204.90
Raw Material Cost
341.36
331.60
425.77
510.40
273.63
138.35
117.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
107.01
55.27
32.35
26.32
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
26.61
24.91
13.00
1.28
0.07
0.18
0.27
Selling and Distribution Expenses
72.04
53.76
47.33
52.19
36.84
30.99
28.85
Other Expenses
-0.29
0.08
2.19
-6.74
-3.30
-2.03
-1.84
Total Expenditure (Excl Depreciation)
437.08
411.08
508.01
603.49
332.83
181.57
154.57
Operating Profit (PBDIT) excl Other Income
111.8
45.199999999999996
94.3
248.70000000000002
167.8
63.7
50.300000000000004
Other Income
20.64
25.08
32.33
-6.56
12.05
14.45
13.05
Operating Profit (PBDIT)
183.85
124.19
180.83
271.73
175.26
88.38
63.74
Interest
26.61
24.91
13.00
1.28
0.07
0.18
0.27
Exceptional Items
-5.57
-0.52
-6.55
-22.93
-5.22
0.00
-0.50
Gross Profit (PBDT)
207.48
124.72
176.53
341.75
227.05
106.91
87.43
Depreciation
55.06
59.65
61.59
51.87
22.20
11.81
1.68
Profit Before Tax
96.62
39.12
99.68
195.65
147.76
76.38
61.28
Tax
22.65
3.22
10.31
24.49
28.39
10.23
8.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
72.19
34.79
87.71
171.16
119.37
66.15
52.83
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
72.19
34.79
87.71
171.16
119.37
66.15
52.83
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.77
0.31
-0.02
0.00
0.00
0.00
-0.05
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
72.96
35.10
87.69
171.16
119.37
66.15
52.79
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,189.78
1,156.97
1,009.49
971.82
796.89
348.11
281.96
Earnings per share (EPS)
0.52
0.25
0.62
1.22
0.85
0.47
0.38
Diluted Earnings per share
0.52
0.25
0.62
1.22
0.85
0.47
0.38
Operating Profit Margin (Excl OI)
19.71%
8.65%
14.43%
26.57%
28.16%
25.33%
23.92%
Gross Profit Margin
27.64%
21.64%
26.78%
29.05%
33.95%
35.96%
30.73%
PAT Margin
13.15%
7.62%
14.56%
20.09%
23.84%
26.97%
25.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 20.27% vs -24.24% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 107.98% vs -59.98% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 64.68% vs -33.27% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 6.83% vs 91.54% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Guangzhou Jet Biofiltration Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
548.84
0
548.84
Other Operating Income
0.00
0.00
0.00
Total Operating income
548.84
0
548.84
Raw Material Cost
341.36
0
341.36
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
26.61
0
26.61
Selling and Distribution Expenses
72.04
0
72.04
Other Expenses
-0.29
0.00
-0.29
Total Expenditure (Excl Depreciation)
437.08
0
437.08
Operating Profit (PBDIT) excl Other Income
111.76
0.00
111.76
Other Income
20.64
0
20.64
Operating Profit (PBDIT)
183.85
0
183.85
Interest
26.61
0
26.61
Exceptional Items
-5.57
0
-5.57
Gross Profit (PBDT)
207.48
0
207.48
Depreciation
55.06
0
55.06
Profit Before Tax
96.62
0
96.62
Tax
22.65
0
22.65
Provisions and contingencies
0
0
0.00
Profit After Tax
72.19
0
72.19
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
72.19
0
72.19
Share in Profit of Associates
0
0
0.00
Minority Interest
0.77
0
0.77
Other related items
0.00
0.00
0.00
Consolidated Net Profit
72.96
0
72.96
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,189.78
0
1,189.78
Earnings per share (EPS)
0.52
0
0.52
Diluted Earnings per share
0.52
0
0.52
Operating Profit Margin (Excl OI)
19.71%
0%
0.00
19.71%
Gross Profit Margin
27.64%
0%
0.00
27.64%
PAT Margin
13.15%
0%
0.00
13.15%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 54.88 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 20.27% vs -24.24% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 7.30 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 107.98% vs -59.98% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.32 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 64.68% vs -33.27% in Dec 2023

Annual - Interest
Interest 2.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.83% vs 91.54% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.71%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023